Cargando…
Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840584/ https://www.ncbi.nlm.nih.gov/pubmed/27384439 http://dx.doi.org/10.3904/kjim.2015.295 |
_version_ | 1783304606775771136 |
---|---|
author | Yim, Eunjung An, Ho Jung Cho, Uiju Kim, Youngwoo Kim, Seung Hoon Choi, Yeon-Geun Shim, Byoung Yong |
author_facet | Yim, Eunjung An, Ho Jung Cho, Uiju Kim, Youngwoo Kim, Seung Hoon Choi, Yeon-Geun Shim, Byoung Yong |
author_sort | Yim, Eunjung |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5840584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-58405842018-03-08 Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor Yim, Eunjung An, Ho Jung Cho, Uiju Kim, Youngwoo Kim, Seung Hoon Choi, Yeon-Geun Shim, Byoung Yong Korean J Intern Med Letter to the Editor The Korean Association of Internal Medicine 2018-03 2016-07-07 /pmc/articles/PMC5840584/ /pubmed/27384439 http://dx.doi.org/10.3904/kjim.2015.295 Text en Copyright © 2018 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Yim, Eunjung An, Ho Jung Cho, Uiju Kim, Youngwoo Kim, Seung Hoon Choi, Yeon-Geun Shim, Byoung Yong Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title | Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title_full | Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title_fullStr | Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title_full_unstemmed | Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title_short | Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
title_sort | two different kit mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840584/ https://www.ncbi.nlm.nih.gov/pubmed/27384439 http://dx.doi.org/10.3904/kjim.2015.295 |
work_keys_str_mv | AT yimeunjung twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT anhojung twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT chouiju twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT kimyoungwoo twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT kimseunghoon twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT choiyeongeun twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor AT shimbyoungyong twodifferentkitmutationsmayleadtodifferentresponsestoimatinibinmetastaticgastrointestinalstromaltumor |